Education Geriatrics Neurology Pharmacology and toxicology RX Studies Opicapon: double benefit for motor function and sleep in Parkinson’s disease Sleep disorders are among the most common non-motor Parkinson’s symptoms. The targeted treatment of sleep disorders is an important part of Parkinson’s therapy and can significantly improve quality of life....…
View Post 9 min This content is machine translated Parkinson's disease: progressive and clinically heterogeneous Individualized management of motor and non-motor symptoms Primary care providers are the central point of contact for the early detection of Parkinson’s disease, but collaboration with neurological specialists is essential. The diagnosis is still primarily made clinically....…
View Post 8 min This content is machine translated New perspectives for clinics and research Ageing, cellular senescence and Parkinson’s disease Parkinson’s is one of the most common neurodegenerative diseases and continues to pose major challenges for neurology. It has long been clear that age is the decisive risk factor –...…
View Post 12 min This content is machine translated Parkinson's disease Individual therapy management for an optimized outcome – an update Parkinson’s disease is one of the most common neurodegenerative diseases, which manifests itself with motor symptoms such as slowness of movement (bradykinesia), tremors at rest (resting tremor) and muscle stiffness...… CME-Test
View Post 9 min This content is machine translated Pathogenesis, diagnostics and therapeutic interventions Sarcopenia in Parkinson’s disease Parkinson’s disease and sarcopenia are two signs of ageing that mutually reinforce each other: While PD is characterized by the progressive loss of nigrostriatal dopamine neurons and abnormal α-synuclein deposits,...…
View Post 9 min This content is machine translated Oxidative stress and neurodegeneration Insights and therapeutic strategies for Parkinson’s disease Parkinson’s disease (PD) is a neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Oxidative stress is increasingly being discussed as a key...…
View Post 13 min This content is machine translated Parkinson's disease Individual therapy management for an optimized outcome – an update Parkinson’s disease is one of the most common neurodegenerative diseases, which manifests itself with motor symptoms such as slowness of movement (bradykinesia), tremors at rest (resting tremor) and muscle stiffness...… CME-Test
View Post 8 min This content is machine translated Neurology Change of perspective and looking in the same direction The focus of the German Neurological Society’s most successful congress to date with 7300 participants was the motto “Neurology and Immunology – Joint Perspectives”. In addition to (neuro-)immunological topics such...…
View Post 4 min This content is machine translated Parkinson's Pathophysiology, classification and effective treatment strategies Parkinson’s disease is clinically defined by the main motor symptoms resulting from nigrostriatal degeneration. However, it is now assumed that the disease usually consists of several pathologies. What new findings…
View Post 11 min This content is machine translated Parkinson's disease and movement disorders Optimized therapy management for a better quality of life The International Parkinson and Movement Disorder Society (MDS) brings together thousands of clinicians, researchers, trainees and industry supporters each year who are interested in current research and approaches to the…
View Post 8 min This content is machine translated Neurology Expecting the unexpected – a look into the future of diagnostics and therapy As the leading association in the field of neurology, the EAN is always striving to do pioneering work by developing new approaches for the meeting and exchange of scientific knowledge.…
